Among patients with multidrug-resistant tuberculosis (MDR-TB), adverse events related to treatment with linezolid and injectable drugs were found to be more common compared with those related to bedaquiline and delamanid, according to a multicenter, prospective observational study published in Clinical Infectious Diseases.

Treatment with an updated fixed-dose combination (FDC) of rifampicin/isoniazid/ pyrazinamide may decrease the risk for insufficient exposure to rifampicin among children with tuberculosis (TB) infection, according to results of a prospective study published in Clinical Infectious Diseases.

More than half of tuberculosis (TB) patients with newly diagnosed hyperglycemia at TB treatment initiation have unresolved hyperglycemia at the end of their follow-up period, according to data from a meta-analysis published in BMC Infectious Diseases. Findings suggest a need for diabetes mellitus (DM) screening at more frequent intervals during TB treatment.